Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies.
Vivek Y ReddyYue ZhongAlysha M McGovernStacey L AmorosiMeghan B GavaghanDeanna S HertzKaywei LowScott FreemanDavid R HolmesPublished in: ClinicoEconomics and outcomes research : CEOR (2024)
LAAC yielded the lowest overall and patient costs. Warfarin costs were largely driven by clinical events, which may represent an unplanned financial burden for patients. These considerations should be incorporated into shared decision-making discussions about stroke prophylaxis strategies.
Keyphrases
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- direct oral anticoagulants
- prognostic factors
- affordable care act
- peritoneal dialysis
- healthcare
- venous thromboembolism
- risk factors
- oral anticoagulants
- cerebral ischemia
- blood brain barrier
- subarachnoid hemorrhage